Proteome Sciences is a CRO specializing in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterize proteins and their associated post-translational modifications. By using LC-MS2, SysQuant®, and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up- or down-regulated with disease progression or drug treatment.
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue’s InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue samples. UltiMapper™ kits are fully optimized mIHC panels that provide uninhibited co-localization of multiple markers for deep single-cell phenotyping.
Lonza Bioscience Solutions provides life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software for biomanufacturing. Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical and biotechnology companies, as well as academic and government research institutions. Primary brands include Clonetics™ Primary Cells, BioWhittaker™ Media, RAFT™ 3D Cell Culture System, Nucleofector™ Transfection Technology, MycoAlert™ Mycoplasma Detection Assay, PyroGENE™ rFC Endotoxin Detection Assay, PyroTec™ PRO Robotic Solution and WinKQCL™ Endotoxin Testing Analysis Software, MODA™ Environmental Monitoring Solutions.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and
cellular therapy. For over 25 years, our innovative tools have been used to obtain, analyze, and
utilize cells. 2,000 employees in 15 international locations are dedicated to helping researchers and
clinicians make a greater impact on science and health
Myriad RBM, Inc. is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services. Myriad RBM’s internally developed and manufactured immunoassay kits based on Multi-Analyte Profiling (MAP) and ultrasensitive Single-Molecule Array (SimoaTM) technology, provide reproducible and quantitative data for hundreds of human proteins.
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
PromoCell is the premier manufacturer of cell culture products. PromoCell offers broad range of human primary cells, stem cells and blood cells, optimized cell culture media, and a comprehensive line of cell biology research products. Our cell culture products provide scientists with physiologically accurate models, and therefore enable them to obtain better research results. As the original manufacturer, PromoCell is committed to the highest possible ethical and legal standards
Marks & Clerk are committed to providing exceptional intellectual property advice around the
world, helping you to navigate the complexities of IP, patents, trade marks and design protection.
Innovation is the life-blood of business and it’s vital that you do not overlook the need to protect your
intellectual property. From the capture of an idea, to the enforcement or defence of rights in disputes
Marks & Clerk is your expert partner to ensure your IP is protected and fully exploited. Today’s local
is tomorrow’s global – and with our diverse team of practitioners, you’re always supported by a
network of experts.
GE Healthcare Life Sciences, we accelerate precision medicine by helping researchers,
pharmaceutical companies and clinicians discover and make new medicines and therapies. We
provide expertise, technology and services for a wide range of areas within the life sciences industry,
including the manufacture of contrast agents for diagnostic imaging, basic research of cells and
proteins and technologies that enable large-scale manufacturing of vaccines, biologics and cell
therapy. The emergence of cell therapy as a frontline treatment for challenging diseases, including
cancer, is rapidly changing the healthcare landscape. Our Cell Therapy business provides the
tools, technology and processes to enable customers from pharmaceutical manufacturing as part
of our Cell Processing segment, to clinicians and technicians in our Cell Banking and Point of Care
business segments. We are investing in the field for the long-term, and partnering with pharma,
biotech and clinical researchers. GE brings expertise in quality, global distribution, research and
development and regulatory that will transform cell therapy from small-scale treatment to a globallyaccessible
Champions Oncology provides an end-to-end range of research and development solutions and services, from cell lines to modeling treatment in the clinic using PDX models, that improve the productivity of oncology drug development. Using both in vitro and in vivo testing platforms, companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios. Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
Mi-mAbs is an innovative integrated immunotechnology (a consortium) center designed to accelerate the development of new immunotherapy antibodies (mAbs, ADC, Bi-specifics) against cancer and inflammatory diseases. Open to the best targets of academic and industrial research, Mi-mAbs generates antibodies and validate them. Mim-Abs, a multi-disciplinary team, involving experts in hybridoma, molecular biology, biochemistry, immunochemistry and in vitro/in vivo immunopharmacology.
From research to therapy, Horizon Discovery drives the application of gene editing and gene modulation. Innovative tools and services enable scientists to gain a greater understanding of the genetic drivers behind disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.
MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences, drug discovery and development and clinical diagnostics fields. Our special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas.